Respiratory Distress Syndrome (RDS). Respiratory distress syndrome of newborn
Conditions
Interventions
Intervention 1: Intervention group: Includes premature neonates with RDS diagnosis. In this group, samples (n=30) received intratracheal Beraksurf (produced by Tekzima, Iran) at a dose of 4 cc / kg ev
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 2 Days
Inclusion criteria
Inclusion criteria: Parents consent to participate study premature neonates with a gestational age of less than 34 weeks premature neonates with diagnosis of RDS and candidates for surfactant A maximum of 8 hours have elapsed since the birth
Exclusion criteria
Exclusion criteria: No parents consent to participate study Newborns with congenital heart diseases and other life threatening congenital anomalies. Adverse drug effects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improved outcomes in RDS. Timepoint: Before intervention and after intervention. Method of measurement: the need for mechanical ventilation, Venous Blood Gas.;Mortality. Timepoint: During the hospital stay. Method of measurement: Dead / alive.;Drug-related complications. Timepoint: During the hospital stay. Method of measurement: Yes/No. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNiknaz Kabiri
Iran University of Medical Sciences
Outcome results
None listed